ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,770Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 337

$545K Total Retail Price of All Prescriptions

Rank: 57 out of 337

432 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 9,536 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 703 643 1 1
OMEPRAZOLE 456 337 2 4
LEVOTHYROXINE SODIUM 447 339 3 5
AMLODIPINE BESYLATE 446 406 4 3
LISINOPRIL 417 366 5 2
HYDROCHLOROTHIAZIDE 401 369 6 9
ATENOLOL 322 275 7 10
METOPROLOL TARTRATE 304 279 8 6
HYDROCODONE-ACETAMINOPHEN 282 205 S3 9 13
METFORMIN HCL 276 221 10 12
FUROSEMIDE 248 230 11 8
SERTRALINE HCL 243 225 12 18
LOSARTAN POTASSIUM 210 195 13 15
FELODIPINE ER 188 184 14 79
ATORVASTATIN CALCIUM 176 142 15 7
DOXAZOSIN MESYLATE 167 156 16 68
WARFARIN SODIUM 161 151 17 11
TRAZODONE HCL 156 138 18 16
CITALOPRAM HBR 147 112 19 17
CRESTOR 129 114 20 29
GABAPENTIN 124 95 21 20
SYNTHROID 119 90 22 41
QUINAPRIL HCL 116 116 23 50
POLYETHYLENE GLYCOL 3350 105 67 24 47
PREDNISONE 103 61 25 40
TRAMADOL HCL 99 72 26 32
METOPROLOL SUCCINATE 94 85 27 21
RANITIDINE HCL 93 58 28 30
PROAIR HFA 90 67 29 38
LOVASTATIN 88 68 30 24
ISOSORBIDE MONONITRATE ER 86 86 31 70
ENALAPRIL MALEATE 78 78 32 37
MELOXICAM 78 68 32 54
NEXIUM 76 61 34 56
ZOLPIDEM TARTRATE 75 48 35 23
PAROXETINE HCL 74 58 36 46
TAMSULOSIN HCL 74 58 36 25
FLUTICASONE PROPIONATE 73 55 38 34
FLUOXETINE HCL 72 38 39 57
AZITHROMYCIN 68 48 40 51
CLOPIDOGREL 66 59 41 42
AMITRIPTYLINE HCL 65 39 R 42 75
BISOPROLOL FUMARATE 62 51 43 67
JANUVIA 62 53 43 81
ADVAIR DISKUS 61 49 45 44
ZETIA 59 46 46 89
BYSTOLIC 58 45 47 91
FENOFIBRATE 56 25 48 48
PANTOPRAZOLE SODIUM 55 42 49 36
LEVOXYL 50 41 50 90
TRIAMTERENE-HCTZ 50 33 50 39
SPIRIVA 50 31 50 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.